Top Markets
#1 Islamic Coin Islamic Coin +151.30%
#2 Akedo Akedo +77.68%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.65%
#5 Cross Cross +44.14%
#6 Black Phoenix Black Phoenix +33.98%
#7 Velvet Velvet +25.65%
#8 Cap Cap +25.20%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.99%
#10 Palladium Network Palladium Network +12.46%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
Classement en actions #38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
Prix de l'action
$0.83030862
Dernière synchronisation: 2024-06-27
Capitalisation boursière
$726.64K
Changement (1 jour)
-1.35%
Changement (1 an)
0.00%
Pays
DE
Échange Epigenomics AG (ECX)

Catégorie

Healthcare
Le prix ECX avec la capitalisation boursière de B
Epigenomics AG Epigenomics AG
ECX
$0.83030862
Capitalisation boursière de Epigenomics AG(ECX)
Capitalisation boursière: $726.64K
En August 2026, Epigenomics AG a une capitalisation boursière de $726.64K. Cela fait de Epigenomics AG la 38936th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Epigenomics AG du 2014 au 2026
ECX par rapport au top 5 des plus populaires stocks
Prix pour ECX L’actif B La capitalisation boursière de B Résultats
Epigenomics AG Epigenomics AG
$6,249,829 $726.64K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +752,711,453.14%
Epigenomics AG Epigenomics AG
$5,104,349 $726.64K
Apple Inc. Apple Inc.
AAPL
$4.467T +614,753,146.04%
Epigenomics AG Epigenomics AG
$4,769,910 $726.64K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +574,474,192.49%
Epigenomics AG Epigenomics AG
$4,227,935 $726.64K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +509,200,320.84%
Epigenomics AG Epigenomics AG
$3,261,547 $726.64K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +392,811,288.04%